Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep283 | Clinical case reports - Pituitary/Adrenal | ECE2016

Long-term remission (cure?) of acromegaly after discontinuation of somatostatin analogs

Gheorghiu Monica Livia , Vargatu Iulia , Dumitrascu Anda , Caragheorgheopol Andra

In acromegaly, treatment with somatostatin analogs (SSA) normalizes growth hormone (GH) and insulin-like growth factor 1 (IGF1) secretion in about half of the patients. Usually, the disease relapses biochemically within few months after treatment withdrawal.We present two acromegalic patients, women of 49 and 53 years at diagnosis, respectively, who achieved stable remission of the disease after medical treatment withdrawal. One had a microadenoma, the o...

ea0041ep1066 | Thyroid (non-cancer) | ECE2016

Hypertrophic Hashimoto’s thyroiditis mimicking thyroid lymphoma

Alexandru Niculescu Dan , Iorgulescu Radu , Dumitrascu Anda , Poiana Catalina

Introduction: Hashimoto’s thyroiditis (HT) is a well known risk factor for thyroid lymphoma. A rapidly enlarging goiter accompanied by lymph nodes pressure on surrounding structures usually suggest the development of thyroid lymphoma.Case report: An 85 years old hypertensive women presented for a massive goiter extending from the lower jaw to clavicle which increased in size for the last 5 months. She also complained of dysphagia, hoarseness and sho...

ea0038p162 | Neoplasia, cancer and late effects | SFEBES2015

Outcome of insulinomas diagnosed in a tertiary endocrine centre

Trifanescu Raluca , Baciu Ionela , Gheorghiu Monica , Dumitrascu Anda , Poiana Catalina

Background: Insulinomas, the most common functional neuroendocrine tumours of the pancreas, are usually sporadic, benign and solitary.Aims: To assess biochemical data, localisation and treatment outcome of insulinomas diagnosed in a tertiary endocrine centre.Patients and methods: Twenty-five patients (14 F/11 M), aged 49.1±14.1 years, diagnosed with insulinoma in a Neuroendocrine Tumours centre between 2000 and 2014 were retro...

ea0034p133 | Clinical practice/governance and case reports | SFEBES2014

Pituitary apoplexy during a second pregnancy in a woman with prolactinoma

Gheorghiu MonicaLivia , Caragheorgheopol Andra , Dumitrascu Anda , Ionescu Virgil

Introduction: Pituitary apoplexy is a rare syndrome due to hemorrhagic infarction of a pituitary adenoma. It may be clinically overt (sudden, severe headache, visual disturbances, impairment in pituitary function, and altered consciousness), or subclinical. Pregnancy is a rare predisposing factor, which may raise difficulties in the diagnosis and treatment.Case presentation: A 25 years woman diagnosed with a 1/0.8 cm prolactinoma, initial serum PRL 61.5 ...

ea0032p221 | Clinical case reports – Pituitary/Adrenal | ECE2013

Complex hypothalamic disorder after childhood histiocytosis X

Gheorghiu Monica Livia , Caragheorgheopol Andra , Dumitrascu Anda , Poiana Catalina

Introduction: Histiocytosis X is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Its manifestations range from isolated bone lesions to multisystem disease. Seen mostly in children, multifocal histiocytosis may involve in 50% of cases the pituitary stalk, leading to diabetes insipidus and usually permanent pituitary deficiencies. We present an adult patient with a com...

ea0020p224 | Endocrine tumours and neoplasia | ECE2009

Lanreotide effects on glucose metabolism in evolutive acromegaly in remission during chemotherapy

Galoiu Simona , Purice Mariana , Hortopan Dan , Dumitrascu Anda , Coculescu Mihail

Lanreotide has long been used in the therapy of GH secreting pituitary adenomas and other somatostatin receptor positive neuroendocrine tumors.Aims: To determine the impact on glucose metabolism of the 6 months of lanreotide therapy, beside of the antisecretory and antiproliferative effects.Patients and methods: Seven patients with active acromegaly treated with lanreotide, admitted in the Department of Neuroendocrinology, Institut...

ea0073pep13.4 | Presented ePosters 13: Pituitary and Neuroendocrinology | ECE2021

Long term management in aggressive thyrotropinoma

Stanca Oana , Stancu Cristina , Dumitrascu Anda , Badiu Corin

IntroductionThyrotropinoma is a rare pituitary tumor ( <2% of pituitary adenomas) arising from PIT1-lineage cells, which expresses and secrete TSH. In most cases, the etiology is unknown but rare cases have been described to arise in context of MEN 1 syndrome. Diagnosis is often delayed by confusion with primary hyperthyroidism, which determine the tumor to be already large and invasive at the time of diagnosis. GH and prolactin cosecretion is an increas...

ea0081p753 | Thyroid | ECE2022

Somatostatin analog therapy in advanced sporadic medullary thyroid carcinoma: a case report

Dumitriu Roxana , Cristiana Calin , Florentina Burcea Iulia , Dumitrascu Anda , Poiana Catalina

Introduction: Medullary thyroid carcinoma (MTC) is an aggressive neuroendocrine tumor derived from C cells that is responsible for approximately 5% of the gland malignancies, most of them occuring sporadically. Lymph node metastasis may occur early in disease pathogenesis and is one of the most important negative prognostic factor. Surgery is the only curative therapy while other chemotherapeutic options are limited. Neuroendocrine differentiated C cells may express somatostat...

ea0081ep619 | Endocrine-Related Cancer | ECE2022

The different faces of a long-lasting metastasized pancreatic neuroendocrine tumor with calcitonin paraneoplastic secretion and cardiac carcinoid

Ilinca Diculescu Rucsandra , Burcea Iulia Florentina , Dumitrascu Anda Simona , Boldeanu Cosmin , Iftimie Madalina- Elena , Poiana Catalina

Introduction: Besides medullary thyroid carcinoma (MTC), increased calcitonin serum concentrations may be due, rarely, to neuroendocrine tumour (NET) ectopic secretion, especially those of the foregut (pancreatic/lung). Patients with NETs and right-sided heart failure due to cardiac carcinoid have a worse prognosis than those presenting without. Case presentation: We present the case of a 72-year-old female with a history of an initially considered well-...

ea0081ep1050 | Thyroid | ECE2022

Metastatic papillary thyroid carcinoma - a multidisciplinary approach

Manole Tiberiu , Baciu Ionela Florina , Dumitrascu Anda , Goldstein Liviu , Poiana Catalina

Introduction: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. It represents over 80% of all follicular derived well-differentiated thyroid cancers. Despite the fact that the majority of PTCs are well differentiated and have a low rate of local invasion, recurrences, or metastases, there are complex cases which require a multidisciplinary team for a favourable result.Methods: Clinical examination, blood tests, scintigraphy, CT s...